Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Tauriga Sciences, Inc. (TAUG : OTC)
 
 • Company Description   
Tauriga Sciences, Inc. is a diversified life sciences company focused on the development of a proprietary technology platform in the synthetic biology space. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Tauriga Sciences, Inc. is headquartered in Danbury, Connecticut.

Number of Employees: 2

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.01 Daily Weekly Monthly
20 Day Moving Average: 1,250,278 shares
Shares Outstanding: 312.99 (millions)
Market Capitalization: $3.10 (millions)
Beta: 2.15
52 Week High: $0.09
52 Week Low: $0.01
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -23.85% -19.92%
12 Week -48.71% -43.45%
Year To Date -68.67% -62.47%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
4 NANCY COURT SUITE 4
-
WAPPINGERS FALLS,NY 12590
USA
ph: 917-796-9926
fax: -
None http://www.tauriga.com
 
 • General Corporate Information   
Officers
Seth M. Shaw - Chief Executive Officer and Director
Kevin P. Lacey - Chief Financial Officer
Dr. David L. Wolitzky - Director
Thomas J. Graham - Director
James V. Rosati - Director

Peer Information
Tauriga Sciences, Inc. (CHCR)
Tauriga Sciences, Inc. (ESRX)
Tauriga Sciences, Inc. (MYDP)
Tauriga Sciences, Inc. (GBCS)
Tauriga Sciences, Inc. (LAXAF)
Tauriga Sciences, Inc. (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 87669X205
SIC: 2833
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 12/01/21
Next Expected EPS Date: 06/01/22
Share - Related Items
Shares Outstanding: 312.99
Most Recent Split Date: 7.00 (0.01:1)
Beta: 2.15
Market Capitalization: $3.10 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 06/01/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 9.90
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: 37.33%
vs. Previous Quarter: -3.74%
ROE
03/31/22 - -
12/31/21 - -1,398.84
09/30/21 - -535.92
ROA
03/31/22 - -
12/31/21 - -277.12
09/30/21 - -193.75
Current Ratio
03/31/22 - -
12/31/21 - 0.68
09/30/21 - 1.00
Quick Ratio
03/31/22 - -
12/31/21 - 0.53
09/30/21 - 0.80
Operating Margin
03/31/22 - -
12/31/21 - -1,957.84
09/30/21 - -1,616.72
Net Margin
03/31/22 - -
12/31/21 - -1,957.84
09/30/21 - -1,616.72
Pre-Tax Margin
03/31/22 - -
12/31/21 - -1,957.52
09/30/21 - -1,616.43
Book Value
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
Inventory Turnover
03/31/22 - -
12/31/21 - 0.50
09/30/21 - 0.51
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©